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BACKGROUND: The purpose of this study is to review the short-term outcome of patients with biliary
atresia (BA) treated by the Kasai operation at our institution.
METHODS: Ninety-two BA patients treated by the Kasai operation between January 1996 and December
2002 were reviewed. The diagnosis of BA was confirmed by intraoperative cholangiography. The outcome of
treatment was categorized into two groups: jaundice-free (total bilirubin < 2 mg%) and persistent jaundice
(≥ 2 mg%). The outcome of Kasai operation was evaluated 1 year after surgery. Data are expressed as mean ± SD.
RESULTS: Average age at the time of surgery was 90.26 ± 36.44 days. Only 22.8% (21/92) of patients had
Kasai operation before 60 days of age. Histologically, 49 patients (54.4%) had liver fibrosis at the time of
surgery. Of 92 patients, 17 were not included in outcome evaluation as they were less than 1-year post-
surgery. Therefore, 75 patients could be evaluated for the outcome. Thirty-eight patients (50.67%) 
were jaundice-free 1 year after surgery. Liver histology and age at the time of the Kasai operation did not
influence early outcome. The most common complication was ascending cholangitis.
CONCLUSION: Half of our BA patients who underwent Kasai operation were jaundice-free 1 year after
surgery. The lack of impact of age and liver pathology on outcome is presumably due to the briefness of
the follow-up. In general, our patients underwent Kasai procedure too late. It is therefore important for
us to conduct a campaign to highlight the plight of these patients and the urgency of referral for neonates
with jaundice. [Asian J Surg 2006;29(3):188–92]
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Introduction
Biliary atresia (BA), a progressive inflammation and 
obliteration of both extra- and intrahepatic bile ducts, 
is a common problem in early infancy with cholestatic 
jaundice. The outcome is eventual death from liver decom-
pensation or infection when they are left without any
treatment, usually by the 2nd year of life.1 The introduc-
tion of hepatic portoenterostomy by Kasai et al to correct
obliterated extrahepatic bile ducts has improved patient
survival.2 Most surgeons attribute the successful use of
the Kasai operation to early diagnosis, careful surgical
procedure and prevention of postoperative cholangitis.3–5
Nevertheless, liver disease, resulting from antenatal involve-
ment of the intrahepatic bile duct, progresses in patients
who are not treated. The progressive disease culminates
in the end-state of cirrhosis for these patients who will
eventually require liver transplantation.
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In order to define particular aspects of the treatment,
which need to be emphasized, understanding of the ther-
apeutic results is necessary. The purpose of this study 
is therefore to review the short-term outcome of patients
with BA treated by the Kasai operation at our institution.
Materials and methods
During the period from January 1996 to December 2002,
data of all consecutive infants with BA treated by hepatic
portojejunostomy with Roux-en-Y (original Kasai opera-
tion) from the medical records at King Chulalongkorn
Memorial Hospital were reviewed for the following data:
gender, age at the time of surgery, pre- and postoperative
liver function tests, associated malformations, operative
findings and postoperative complications. The majority
of BA patients were investigated for diagnosis by both
ultrasonography and hepatic scintigraphy. The diagnosis
of BA was confirmed by coeliotomy with intraoperative
cholangiography before undergoing Kasai operation.
The outcomes of Kasai operation were assessed at 1 year
after the procedure and categorized into two groups: 
jaundice-free (total bilirubin levels < 2 mg%) and persistent
jaundice (total bilirubin levels ≥ 2 mg%). None of the
patients in this study showed symptoms and signs of fever
or ascending cholangitis (high fever, elevated serum total
bilirubin and leukocytosis) at the time of outcome evalua-
tion. Types of BA were classified as previously described by
Nio and Ohi: type I, atresia of common bile duct; type II,
atresia of common hepatic duct; type III, atresia at porta
hepatis.6 The association between outcome and age at the
time of Kasai operation as well as liver pathology was
analysed using x2 tests. All data are expressed as mean ± SD.
For all statistical analyses, SPSS version 10.0 (SPSS Inc.,
Chicago, IL, USA) was used.
Results
Ninety-two BA patients underwent Kasai operation dur-
ing the review period. There were 42 (45.7%) males and 
50 (54.3%) females with a mean age at the time of surgery
of 90.26 ± 36.44 days (range, 30–210 days). Only 22.8%
(21/92) of the BA patients had the operation before the
age of 60 days (Figure). Out of the 92 patients, 68 (73.9%)
presented with clinical jaundice at birth while the remain-
ing (26.1%) developed recognizable jaundice after the age 
of 1 month. Associated anomalies consisted of cardiac
anomalies in three patients (tetralogy of Fallot, pulmonary
stenosis and patent ductus arteriosus), Turner’s syn-
drome in one patient, acquired prothrombin complex
deficiency in one patient, glucose-6-phosphate dehydro-
genase enzyme deficiency in one patient and ectopic pan-
creas at jejunum in one patient. There was no polysplenia
syndrome detected in this series.
Among the 72 patients investigated by abdominal
ultrasonography, 51.4% (37/72) had visualized gall-
bladder reported by radiologists. Eighty-six patients had
been investigated by hepatobiliary scintigraphy prior 
to operation, and all 86 showed no radiotracer in the
intestine during the 24 hours following scintigraphy.
Mean preoperative liver function levels were as follows:
total bilirubin, 12.31 ± 5.58 mg%; direct bilirubin, 9.12 ±
4.05 mg%; alkaline phosphatase, 1,009.67 ± 522.64 IU/
mL; serum glutamic oxaloacetic transaminase, 262.27 ±
150.01 IU/mL; serum glutamic pyruvic transaminase,
174.08 ± 109.79 IU/mL.
As a result of intraoperative cholangiography, 94.6%
(87/92) of patients had BA type III and the remaining five
had BA type I. There was no BA type II detected in our
series. All patients with BA type III, 44.8% (39/87), had
patent common bile duct while the remaining had atresia
of the common bile duct as well as porta hepatis. Mean
operative time was 206.8 ± 40.6 minutes (range, 105–315
minutes). Pathological report of liver biopsy revealed that
54.4% (49/90) already had liver fibrosis at the time of
operation.
Perioperative complications occurred in eight patients
(8/92 or 8.7%). The complications were prolonged bile
leakage in three patients, wound infection in two patients,
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Figure. Age of patients at the time of Kasai operation.
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sepsis in two patients (both of which resulted in death)
and intestinal perforation at the site other than anasto-
mosis in one. Postoperative complications comprised
cholangitis in 34 patients (38%), gastrointestinal bleeding
from varices in nine patients whose livers were cirrhotic
at the time of Kasai operation (10%) and intestinal
obstruction in two patients (2%). Among 34 patients with
cholangitis, 21 (61.76%) had a single episode only and the
remaining 13 (38.24%) had recurrent episodes.
Among the 92 patients, 17 patients were less than 
1-year post-surgery; therefore, only 75 patients could 
be evaluated for postoperative outcomes. Of these, 38
(50.67%) were jaundice-free, and 37 (49.33%) had persist-
ent jaundice. In the good outcome group, the mean dura-
tion between the operation and jaundice-free onset was
4.82 ± 3.86 months (range, 1–8 months). By using x2 tests,
there was no association between outcome and either age
or liver pathology at the time of the Kasai operation, as
shown in Table 1.
Discussion
At present, the Kasai operation remains the most common
initial management for BA patients at our institution. 
In addition, the timing of surgical intervention for BA
patients is a crucial factor. Most of the major series have
confirmed that the best results from Kasai operation are
achieved when patients have the surgery before the age of
60 days.7–12 An analysis of the BA patients treated by the
Kasai operation at our institution showed that most of
them (77.2%) had the surgery quite late. Only 22.8% had
the Kasai operation before 60 days of age. Mass screening
for BA patients by examining all neonatal stools with stool
colour cards, which was previously proposed by Maki 
et al,13 may help patients with quicker diagnosis and surgery
as a promising offensive policy. Alternatively, a campaign
towards primary healthcare providers regarding the impor-
tance of early treatment needs to be urgently conducted.
Notwithstanding the late timing of surgery, 50.67% of
our patients were jaundice-free at the 1-year follow-up.
Previously published data extracted from 1985 to 1994 
by Chandrakamol et al showed a jaundice-free rate of
35.7%.14 The results indicate that there has been an
improvement in surgical outcome at our institution. This
may be attributed to our improved surgical techniques
(mobilization of the liver and magnification using a sur-
gical loupe during dissection of the porta hepatis) and
more advanced knowledge in prevention of postoperative
cholangitis (use of long-term oral antibiotics and short-
term high-dose steroid administration). The jaundice-free
survival rates reported by various authors range from
15.5% to 54.9%.4,5,15–18 A large series reported by Kasai et al
demonstrated that 84 of 245 BA patients (34.3%) achieved
jaundice-free status after surgery (Table 2).5 However, the
outcome and the mean follow-up duration of BA patients
in each institution were different; therefore, it is not
appropriate to compare the results from different studies.
The outcome of Kasai operation in this study was analysed
at 1 year after surgery, which is quite short, and long-term
follow-up has to be further evaluated.
Table 1. Outcome of Kasai operation and patient age and liver
histology at the time of surgery
Good Poor p
outcome outcome
Age at operation 0.801
< 60 d 7 6
≥ 60 d 31 31
Liver histology 0.902
No liver fibrosis 18 17
Liver fibrosis +ve 20 20
Table 2. Jaundice-free rate in biliary atresia patients after Kasai operation
Reference Period Place Patients, n
Jaundice-free rate, Mean follow-up time 
n (%) (range)
Kasai et al5 1953–1987 Japan 245 84 (34.3) 1–34 yr
Lilly et al15 1973–1988 Colorado 125 35 (28.0) 86 mo (1–15 yr)
Lin et al16 1976–1989 Taiwan 60 23 (38.3) 7.2 yr (1–14 yr)
Wildhaber et al29 1974–2001 Michigan 81 31 (38.0) 92 mo (1–27 yr)
Carceller et al30 1974–1998 Quebec 63 27 (43.0) 1–28 yr
Current study 1996–2002 Thailand 75 38 (50.6) 1 yr after surgery
Approximately half of the BA patients (54.4%) had
liver fibrosis at the time of surgery. Hays and Kimura19
reported a relationship between liver fibrosis and progno-
sis. In their series, no infant whose liver biopsy showed
severe fibrosis survived. Nevertheless, our data unfolded
no association between outcome and the presence of liver
fibrosis during surgery (p > 0.05). In addition, there was no
association between outcome and the age of patients at
the time of surgery. These observations are probably due
to the short follow-up period. Longer period to assess out-
come may reveal significant associations.
Ascending cholangitis is the most common postop-
erative complication, which was noted in 38% (34/90) of
our patients after Kasai operation in addition to the com-
mon perioperative complication of abdominal surgery.
Cholangitis frequently results in the cessation of bile flow,
and repeated attacks cause a progressive deterioration in
hepatic function. Prevention of cholangitis is therefore an
essential factor for maintaining bile drainage. As a result,
various types of antireflux procedures have been devel-
oped,20–22 but none is superior to the original Roux-en-Y
procedure.23 At our institution, only hepatic portojejunos-
tomy with Roux-en-Y or “the original Kasai operation” has
been carried out since 1985 without additional modifica-
tions of the procedure. The incidence of ascending cholan-
gitis in our series is comparable to the 40–60% rate of
others.3,24,25 Cholangitis is reported to be a risk factor
associated with portal hypertension.26 Because portal
hypertension could develop even in BA patients who are
jaundice-free, examination of oesophageal varices should
be included in routine surveillance.
Despite the successful correction of extrahepatic biliary
obliteration by Kasai operation, the on-going inflamma-
tion of intrahepatic involvement still exists. The on-going
process elucidates why ultimate liver fibrosis is inevitable
in a number of patients, who eventually require liver trans-
plantation. Some authors have also improved survival rates 
via liver transplantation as a primary therapy for BA
patients.27,28 However, we think that liver transplantation
should not be the first line of treatment in our country
because of the shortage of liver donors and the very high
cost of the operation. Therefore, liver transplantation in BA
patients at our hospital was performed only in selected
patients, who experienced end-stage liver cirrhosis and can
comply with strict long-term follow-up.
In conclusion, half of our BA patients, who underwent
Kasai operation, were jaundice-free at 1 year after surgery.
The lack of impact of age and liver pathology on outcome
is presumably due to the briefness of the follow-up. In
general, our patients underwent the Kasai procedure too
late. It is therefore important for us to conduct a campaign
to highlight the plight of these patients and the urgency
of referral for neonates with jaundice.
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